Adline Chem Lab News

Adline Chem Lab Receives BSE Approval for Promoter Reclassification, Gets Warning for Disclosure Delay

Adline Chem Lab Limited received BSE approval to reclassify 12 promoter shareholders to public category, reducing promoter holding from 29.61% to 25.86% and increasing public holding to 74.14%. BSE issued a warning letter to the company for delayed disclosure of the reclassification application, submitted on February 7, 2025 but disclosed on February 10, 2025, violating the 24-hour disclosure requirement.

Adline Chem Lab Reports Leadership Changes and Quarterly Results

Adline Chem Lab Limited announced significant board changes during its November 12, 2025 meeting. Sarang Pathak resigned from his position as Executive Director-Chairman (Managing Director) and Hemant Parikh stepped down as Non-Executive Promoter Director, both effective from the close of business on November 12, 2025. The company appointed Vrushank Patel as the new Chairman of the Board and authorized him to handle necessary documentation and approvals. The board also approved unaudited standalone financial results for the quarter and half-year ended September 30, 2025, along with noting the statutory auditors' limited review report. The company's cash and cash equivalents increased to 7.36 from 6.32 in the previous period, while it reported a loss before tax of 13.89 for the half-year period.

Adline Chem Lab Limited's Company Secretary Akshita Khandelwal Resigns Due to Personal Reasons

Akshita Khandelwal has resigned from her position as Company Secretary, Compliance Officer, and Key Managerial Personnel of Adline Chem Lab Limited, effective from the close of business on August 14, 2025. The resignation was attributed to personal and unavoidable reasons, with no other material reasons cited for her departure. The company has informed the stock exchange of this change in key personnel as required under regulatory obligations.

Adline Chem Lab Limited Approves Quarterly Financial Results for Quarter Ended June 30, 2025

Adline Chem Lab Limited's Board of Directors approved the unaudited standalone financial results for the quarter ended June 30, 2025, during a meeting held on August 12, 2025. The board noted the Limited Review Report from statutory auditors, which contained no qualifications or modifications. The company also acknowledged a SEBI circular regarding a special window for re-lodgement of transfer requests for physical shares under the Ease of Doing Investments initiative. The financial results were prepared in accordance with Indian Accounting Standards and were reviewed and recommended by the audit committee.